Cargando...
NYSE: CB
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueIngresos Totales | $59.4B+6.5% | $55.8B+12.1% | $49.7B+15.2% | $43.2B+5.4% | $41.0B+13.8% | $36.0B+5.3% | $34.2B+4.5% | $32.7B+1.5% | $32.2B+2.5% | $31.5B |
| Cost of RevenueCosto de Ventas | — | — | — | — | — | — | — | — | — | — |
| Gross ProfitUtilidad Bruta | — | — | — | — | — | — | — | — | — | — |
| Research & DevelopmentInvestigación y Desarrollo | — | — | — | — | — | — | — | — | — | — |
| Selling, General & AdministrativeGastos Generales y Adm. | $4.5B+2.8% | $4.4B+9.3% | $4.0B+18.0% | $3.4B+8.3% | $3.1B+5.3% | $3.0B-1.7% | $3.0B+5.0% | $2.9B+1.9% | $2.8B-8.0% | $3.1B |
| Total Operating ExpensesGastos Operativos Totales | — | — | — | — | — | — | — | — | — | — |
| Operating IncomeUtilidad Operativa | — | — | — | — | — | — | — | — | — | — |
| Other Income/(Expense), NetOtros Ingresos/(Gastos), Neto | $1.3B+26.8% | $1.0B+22.4% | $836.0M+246.7% | -$570.0M-124.1% | $2.4B+138.1% | $994.0M+66.8% | $596.0M+193.0% | -$641.0M-5.6% | -$607.0M-0.3% | -$605.0M |
| Pretax IncomeUtilidad Antes de Impuestos | $13.0B+13.9% | $11.5B+20.2% | $9.5B+45.0% | $6.6B-33.1% | $9.8B+135.8% | $4.2B-20.7% | $5.2B+12.7% | $4.7B+25.1% | $3.7B-24.8% | $5.0B |
| Tax ProvisionImpuestos | $2.4B+33.4% | $1.8B+255.2% | $511.0M-59.3% | $1.3B-1.7% | $1.3B+103.0% | $629.0M-20.9% | $795.0M+14.4% | $695.0M+600.0% | -$139.0M-117.1% | $815.0M |
| Net IncomeUtilidad Neta | $10.6B+10.2% | $9.6B+6.8% | $9.0B+69.9% | $5.3B-37.8% | $8.5B+141.7% | $3.5B-20.7% | $4.5B+12.4% | $4.0B+2.6% | $3.9B-6.6% | $4.1B |
| EBITDA | — | — | — | — | — | — | — | — | — | — |
| Basic EPSUPA Básica | $25.93+13.0% | $22.94+4.4% | $21.97+73.5% | $12.66-34.8% | $19.41+148.2% | $7.82-20.0% | $9.77+14.3% | $8.55+3.5% | $8.26-7.6% | $8.94 |
| Diluted EPSUPA Diluida | $25.68+13.1% | $22.70+4.1% | $21.80+73.7% | $12.55-34.9% | $19.27+147.4% | $7.79-19.8% | $9.71+14.4% | $8.49+3.7% | $8.19-7.7% | $8.87 |